[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$GRI : some good upward movement today People still anticpating Q2 Topline results that were due two weeks ago Should be anytime now.m $TSLA $NVDA $AAPL $AMZN $MSFT $PLTR $AMD $META $GOOGL $GME $AMC $NIO $SOFI $COIN $BTC $ETH $SPY $QQQ $APE $VKTX $INZY $BMRN $MRTX #StockMarket"
X Link @bz9998 2025-10-17T17:08Z XXX followers, XX engagements
"☁☁☁☁ like $GRI moves ☁☁☁☁ Falling🤴 #gold $TSLA $AAPL $NVDA $AMZN $MSFT $META $GOOGL $AMD $NFLX $PLTR $SOFI $COIN $BTC $ETH $SPY $QQQ $GME $AMC $NIO $BABA $kAPA $SOFI $APE GRI bio $GRI $IMUX $HOTH $CRVO $ATNM $BMRN $IBRX $VKTX $INZY $MRTX"
X Link @bz9998 2025-10-17T16:14Z XXX followers, XX engagements
"$RENT $GME $TTWO $AMAT $WMT $CBRL $JDZG $VKTX $FFIE $AMC $GWAV $CRKN $SPY $GNS $HOLO $NVDA $CYN $BSFC $MULN $TSLA $NFLX $QQQ $META Daily live streaming real-time charting mentoring and training. 📈#investing Discord Link Here #Discord Invast Joi"
X Link @JulietLija123 2025-10-17T15:56Z XX followers, XX engagements
"Zacks featured $LLY $NVO $AMGN and $VKTX in its latest analyst blog. Eli Lilly reports Q3 earnings on Oct XX and all eyes are on its GLP-1 blockbusters. Analysts estimate Mounjaro sales at $5.3B and Zepbound at $3.5B. $GS expects the U.S. obesity market to reach $100B by 2030. Lilly and Novo Nordisk dominate but Amgen (MariTide) and Viking Therapeutics (VK2735) are emerging challengers. Zacks rates Eli Lilly a Hold strong growth momentum but a premium valuation at XX forward earnings. #StocksToWatch #investing"
X Link @investseekers 2025-10-17T15:47Z 4100 followers, XXX engagements